IQ-AI ROE 2024

Ką veikia IQ-AI?

IQ-AI Ltd is a leading medical imaging company based in the UK. It was founded in 2006 and has since become a major provider of diagnostic and clinical imaging results. The company offers a wide range of imaging solutions, including software for radiological diagnostics and imaging data evaluation. The business model of IQ-AI is to help medical professionals make more precise diagnoses and better clinical decisions. The company uses cutting-edge technologies to automate and facilitate the interpretation of medical imaging data. This allows doctors and radiologists to quickly and easily create detailed diagnoses and adjust treatment plans accordingly. IQ-AI operates in various business areas, including the development and marketing of imaging solutions, the integration of artificial intelligence into imaging, and the operation of imaging reference centers that create and maintain unique databases of medical imaging results. Among IQ-AI's products, the most widely used is the software product "StoneChecker." StoneChecker is a program used by medical professionals to simplify the diagnosis of kidney stones. The system can process, analyze, and evaluate images of kidney stones from ultrasound, CT, and X-ray images. The results from StoneChecker are then used to support decisions made by medical professionals. The software is used by medical facilities worldwide and is provided by the company for a licensing fee or usage-based costs. Other products and services of IQ-AI include a wide range of medical imaging software. This includes software for heart imaging, software for the diagnosis of brain diseases, and software for breast examinations. The range is continuously expanding to better meet the needs of medical professionals in the future. In recent years, the company has expanded its product range through technological innovation, with the use of artificial intelligence (AI) being an important component. IQ-AI is working to promote the use of AI in medicine, with machine learning methods playing a crucial role. The goal is to accelerate and improve the interpretation of medical images and diagnostic tasks. Another important element on the path to smart healthcare is clinical research. IQ-AI operates a number of clinical research facilities where data on diseases and diagnostic methods are systematically collected, analyzed, and published. In this way, the company has a broad base of data that it uses for the development of new products and the acquisition of new insights. Overall, IQ-AI has established itself as a major provider of medical imaging techniques. The company is a leader in the development of advanced diagnostic software products and is working hard to revolutionize the future of diagnostics. The focus is on improving healthcare for people worldwide. IQ-AI ist eines der beliebtesten Unternehmen auf Eulerpool.com.